Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Bausch & Lomb Incorporated
This study will evaluate the safety and efficacy of BL1107 in adults with primary open-angle glaucoma or ocular hypertension in both eyes. This is a randomized, double-masked, parallel comparison to evaluate two concentrations of BL1107 in both eyes compared with timolol 0.5% for 28 days.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Ocular hypertension or primary open-angle glaucoma in each eye
You may not be if
History of orthostatic hypotension
Any active ocular disease
Anticipated wearing of contact lenses during study
Contraindication to pupil dilation
Clareo Health | Phase 2 Study of BL1107 Eye Drops vs. Timolol in Adults With Primary Open Angle Glaucoma or Ocular Hypertension
